Obinutuzumab in Combination With GDP Chemotherapy in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma
University Health Network, Toronto
University Health Network, Toronto
St. Jude Children's Research Hospital
Oncology Specialists, S.C.
Milton S. Hershey Medical Center
Fred Hutchinson Cancer Center
University of Washington
New Mexico Cancer Research Alliance
Celgene